Sunesis to Present at Upcoming Investor Conferences
February 21 2012 - 7:00AM
Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) today announced that
the Company will present at two upcoming investor conferences.
Daniel Swisher, Chief Executive Officer of Sunesis, will present
at the 2012 Citi Healthcare Conference on Tuesday, February 28,
2012 at 1:30 PM Eastern Time at The Waldorf=Astoria in New York
City.
Eric Bjerkholt, Executive Vice President, Corporate Development
and Finance at Sunesis will present at the 2012 RBC Global
Healthcare Conference on Wednesday, February 29, 2012 at 11:30 AM
Eastern Time at The New York Palace Hotel in New York City.
A live webcast of the presentations will be available on the
Sunesis website at http://ir.sunesis.com. A replay of the webcasts
will be archived on the "Calendar of Events" page in the Investors
and Media section of the Sunesis website for two weeks.
About Sunesis Pharmaceuticals
Sunesis is a biopharmaceutical company focused on the
development and commercialization of new oncology therapeutics for
the treatment of solid and hematologic cancers. Sunesis has built a
highly experienced cancer drug development organization committed
to advancing its lead product candidate, vosaroxin, in multiple
indications to improve the lives of people with cancer. For
additional information on Sunesis, please visit
http://www.sunesis.com.
The Sunesis Pharmaceuticals, Inc. logo is available at
http://www.globenewswire.com/newsroom/prs/?pkgid=8773
SUNESIS and the logo are trademarks of Sunesis Pharmaceuticals,
Inc.
CONTACT: Investor and Media Inquiries:
David Pitts
Argot Partners
212-600-1902
Eric Bjerkholt
Sunesis Pharmaceuticals Inc.
650-266-3717
Sunesis Pharmaceuticals (NASDAQ:SNSS)
Historical Stock Chart
From Jun 2024 to Jul 2024
Sunesis Pharmaceuticals (NASDAQ:SNSS)
Historical Stock Chart
From Jul 2023 to Jul 2024